Tumor suppressors LKB1 and SMARCA4 functionally interact to regulate gene expression across diverse biological

Mohammed Bourouh1,2, Jinhong Kim1, Paola A Marignani1

  • 1Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.

Abstract

Insights

The tumor suppressor liver kinase B1 (LKB1) and SMARCA4 protein collaborate to regulate gene expression in lung cancer. This LKB1-SMARCA4 pathway is crucial for cellular metabolism and is altered in lung tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genomics

Background:

  • Liver kinase B1 (LKB1) is a tumor suppressor kinase regulating metabolism via AMP-activated protein kinase (AMPK).
  • LKB1 is frequently mutated in lung cancer, impacting cellular metabolism and gene expression.
  • LKB1 directly interacts with SMARCA4, a subunit of the SWI/SNF chromatin remodeling complex, linking it to gene regulation.

Purpose of the Study:

  • To investigate the collaborative role of LKB1 and SMARCA4 in regulating gene expression in lung cancer.
  • To elucidate the molecular mechanisms by which LKB1 and SMARCA4 interact to control cellular processes.
  • To determine if the LKB1-SMARCA4 pathway is relevant in human lung tumors.

Main Methods:

  • Utilized in silico analysis of single-cell RNA-seq (scRNA-seq) data from lung cancer cell lines with varying LKB1 and SMARCA4 expression.
  • Identified genes co-regulated by LKB1 and SMARCA4.
  • Correlated findings with bulk RNA-seq data from human lung tumors.

Main Results:

  • LKB1 and SMARCA4 function together to regulate gene expression across multiple biological processes in lung cancer cell lines.
  • Gene expression profiles in LKB1- and SMARCA4-mutant cells showed similarities, indicating a linear pathway.
  • These findings were corroborated in human lung tumors, especially in advanced stages.

Conclusions:

  • LKB1 acts as a critical link between cellular metabolism and gene expression in lung cancer.
  • The LKB1-SMARCA4 interaction, mediated through the SMARCA4-SWI/SNF complex, is a key regulator of gene expression in lung cancer.
  • This pathway represents a potential therapeutic target in lung cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K